{
  "ptid_time": "003_S_5165_2013-08-16",
  "img_path": "/data/qiuhui/data/adni/images/003_S_5165/2013-08-16/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 76,495 mm³, 98.6% above the reference mean. With a Z-score of 2.36 (99.1th percentile), this represents significant enlargement; hippocampal volume measures 6,269 mm³, 17.1% below the reference mean. With a Z-score of -1.66 (4.8th percentile), this represents moderate atrophy; whole brain volume measures 1,107,880 mm³, 2.6% above the reference mean. With a Z-score of 0.34 (63.4th percentile), this represents normal volume ; entorhinal cortex volume measures 3,739 mm³, 8.8% below the reference mean. With a Z-score of -0.60 (27.5th percentile), this represents normal volume ; fusiform gyrus volume measures 17,495 mm³, 7.1% below the reference mean. With a Z-score of -0.61 (27.2th percentile), this represents normal volume ; middle temporal gyrus volume measures 19,446 mm³, 8.9% below the reference mean. With a Z-score of -0.80 (21.3th percentile), this represents normal volume . ",
  "text_data": "Age is 78.8 years. Gender is Male. Education: 12 years. Handedness: Right. Race: White. Medical history: Cardiovascular; Major Surgical Procedures. MMSE: 23.0. MoCA: 21.0. Logical Memory: 2.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.58 SUVR (profound elevated); Amyloid beta: 886.20 pg/mL (normal ); Total tau: 627.90 pg/mL (profound elevated); Phosphorylated tau: 67.40 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant ventricular enlargement (98.6% above mean) and moderate hippocampal atrophy (17.1% below mean), both consistent with neurodegeneration. Elevated T-tau, P-tau, and AV45 (amyloid PET) suggest Alzheimer's pathology, while cognitive scores (MMSE 23, MoCA 21) indicate mild impairment.  \n\n**Diagnosis:** **Dementia (likely Alzheimer’s disease)**  \n**Confidence:** **High**  \n\n*(Key findings: Biomarker evidence of amyloid + tau pathology, structural atrophy in AD-vulnerable regions, and cognitive decline meeting dementia criteria.)*",
  "timestamp": "2025-07-25T20:58:47.026791"
}